{'text': 'FDA APPROVES KYPROLIS® (CARFILZOMIB) FOR COMBINATION USE IN THE TREATMENT OF PATIENTS WITH RELAPSED MULTIPLE MYELOMA', 'publisher': {'href': 'http://www.multivu.com', 'title': 'MultiVu'}, 'created_at': 'Fri, 24 Jul 2015 07:00:00 GMT', 'description': 'FDA APPROVES KYPROLIS® (CARFILZOMIB) FOR COMBINATION USE IN THE TREATMENT OF PATIENTS WITH RELAPSED MULTIPLE MYELOMA  MultiVu', 'url': 'https://news.google.com/rss/articles/CBMigAFBVV95cUxOMmZYOVhFMU1Wa0hab3RhdEZERG9yRV96ZHFzS1BaWUd4TThVOUFLOHB4TXlrQ2lvVUlDT1lGamt2VWhtajdIV2Z2NlpsZEVLb0Nidl9Ta3QxWnB6bnNwNWxzaGlocDZ5X3hWMVc2Zmx3OFJXS1hKNXF4emQ1ZExBeg?oc=5&hl=en-US&gl=US&ceid=US:en'}
